Intimation of newspaper advertisement regarding the publication of unaudited financial results for the quarter and half-year ended September 30, 2025.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed the BSE that it published a newspaper advertisement on October 29, 2025 in the Financial Express (English) and Navshakti (Marathi) editions, containing its unaudited financial results for the quarter and half-year ended September 30, 2025. This is a routine regulatory compliance filing under SEBI's Listing Regulations, required after the board approves quarterly results. No actual financial numbers are disclosed in this particular intimation — those would have been filed separately as the detailed results under SEBI Regulation 33. The filing is signed by Company Secretary Chandni Maru.
This is purely a procedural disclosure and contains no new financial information. Shareholders should refer to the separately filed Q2/H1 FY26 results for actual numbers. Expect no direct impact on the stock price from this filing alone.